Seizure News and Research

Latest Seizure News and Research

Compugen signs research and license agreement with a leading diagnostic company

Compugen Ltd. announced today that it has signed a research and license agreement with a leading diagnostic company covering CGEN-226, a novel biomarker candidate for early detection of preeclampsia.

5 Nov 2009

EFOF's initative to raise epilepsy awareness

Each year, some 50,000 Americans die from seizures and related causes, triggering more deaths annually than breast cancer. The Epilepsy Foundation of Florida (EFOF) is working to educate the public about this condition during November, Epilepsy Awareness Month.

4 Nov 2009

Cyberonics to develop medical devices with cutting edge technology for persons suffering from epilepsy

Cyberonics, Inc. today announced another in a series of collaborations around seizure detection technology aimed at advancing its development of new and more efficacious medical devices for persons suffering from epilepsy.

2 Nov 2009

"Helmets for Hope" campaign launched to raise epilepsy disorder awareness

November is Epilepsy Awareness Month. The Lennox Gastaut Syndrome Foundation (LGSF) and the American Epilepsy Outreach Foundation (AEOF) has joined with Eisai Pharmaceuticals and Lundbeck Pharmaceuticals to co-host the 1st Annual Helmets for Hope(TM) Campaign.

2 Nov 2009

Therap Services to host its 4th annual National Provider Administrator conference in Fishkill

Therap Services is hosting its 4th annual National Provider Administrator conference in Fishkill, NY February 2-4, 2010. Therap provides electronic documentation and communication services to providers of service to people with developmental disabilities.

31 Oct 2009

Genetic mutations cause for SIDS and SUDS

Scientists and clinicians at the Montefiore-Einstein Center for Cardiogenetics have teamed up and found that genetic mutations leading to Long QT Syndrome (LQTS) could be causing electrical malfunctioning of the heart resulting in the mysterious deaths more commonly known as Sudden Infant Death Syndrome (SIDS) and Sudden Unexplained Death Syndrome (SUDS) in people older than 12 months of age.

27 Oct 2009

Protein crucial for insulin regulation may play a role in diabetes

A cellular protein from a family involved in several human diseases is crucial for the proper production and release of insulin, new research has found, suggesting that the protein might play a role in diabetes.

27 Oct 2009

Orexigen Therapeutics announces new data from COR-I, COR-II and COR-Diabetes trials for Contrave

Orexigen® ( )Therapeutics, Inc today announced new data from the COR-I, COR-II and COR-Diabetes trials for Contrave® (bupropion SR/ naltrexone SR) to expand on top-line results announced in July. Contrave is the first of the Company's two late stage candidates for the treatment of obesity.

26 Oct 2009

TV program shares insights on epilepsy, diagnosis and treatment

A recent edition of Immunotherapy Weekly reported that the television program 'Sharing Miracles' featured award-winning actor Danny Glover during the month of September. In this episode, the Hollywood star discussed his career and his battle against epilepsy.

24 Oct 2009

EU policies threaten developing countries drug supplies, report says

A report, released Tuesday, from Oxfam International and Health Action International says the EU is putting big drug companies' interests ahead of "millions of people" in developing countries who do not have access to essential medicines, Agence France-Presse reports (10/20).

22 Oct 2009

Web site marketing fraudulent H1N1 flu supplements warned by the FDA and the FTC

On October 15, 2009, the U.S. Food and Drug Administration (FDA) and the Federal Trade Commission (FTC) issued a joint warning letter to a Web site marketing fraudulent supplements that claim to help prevent the spread of the 2009 H1N1 influenza virus.

20 Oct 2009

Epilepsy Therapy Project unveils My Epilepsy Diary

Epilepsy Therapy Project, a leader in accelerating new therapies for people living with epilepsy and seizures, announces the release of My Epilepsy Diary, a breakthrough data-gathering and reporting product designed to improve epilepsy care and quality of life.

19 Oct 2009

FDA grants marketing approval for Elitek

Sanofi-aventis U.S. announced that the U.S. Food and Drug Administration (FDA) has granted marketing approval for Elitek (rasburicase) to be used for the initial management of plasma uric acid (PUA) levels in adult patients with leukemia, lymphoma, and solid tumor malignancies who are receiving anti-cancer therapy expected to result in tumor lysis syndrome (TLS) and subsequent elevations of plasma uric acid.

19 Oct 2009

Research study on epileptic seizures in individuals with alcohol withdrawal syndrome

Epileptic seizures are the most dramatic and prominent aspect of the "alcohol withdrawal syndrome" that occurs when a person abruptly stops a long-term or chronic drinking habit. Researchers have shown that the flow of calcium ions into brain cells via voltage-gated calcium channels plays an important role in the generation of alcohol withdrawal seizures, because blocking this flow suppresses these seizures.

19 Oct 2009

Postive vote from FDA Advisory Committee for Fampridine-SR 10

Acorda Therapeutics, Inc. today announced the U.S. Food and Drug Administration (FDA) Peripheral and Central Nervous System Drugs (PCNSD) Advisory Committee voted 12 to 1 that clinical data on Fampridine-SR 10 mg twice daily demonstrated substantial evidence of effectiveness as a treatment to improve walking in people with multiple sclerosis (MS) and voted 10 to 2 (1 abstention) that it is clinically meaningful and can be safe for use.

15 Oct 2009

Brain researcher finds how the epilepsy and pain drug works

A Duke University Medical Center researcher who spent years looking for the signals that prompt the brain to form new connections between neurons has found one that may explain precisely how a well-known drug for epilepsy and pain actually works.

14 Oct 2009

National Vaccine Information Center to launch a research fundraising campaign

At the Oct. 2-4, 2009 Fourth International Public Conference on Vaccination sponsored by the non-profit National Vaccine Information Center in Reston, VA, 700 citizens from 44 states and 11 nations raised more than $100,000 to launch an international scientific research fundraising campaign to investigate health differences between vaccinated and unvaccinated children and identify those at risk for suffering vaccine injury.

14 Oct 2009

New neurosurgical procedure may prove helpful for patients with treatment-resistant depression

A new neurosurgical procedure may prove helpful for patients with treatment-resistant depression. Bilateral epidural prefrontal cortical stimulation (EpCS) was found generally safe and provided significant improvement of depressive symptoms in a small group of patients, according to lead researcher Ziad Nahas, M.D. at the Medical University of South Carolina. The data are reported in the on-line issue of Biological Psychiatry.

14 Oct 2009

New study launched to detect DNA alterations linked to sudden cardiac death in sports

The BBVA Foundation and the Cardiology Service of Madrid's Hospital Clínico San Carlos have launched a new study aimed at detecting DNA alterations linked to sudden cardiac death in sports. Genetic testing is vital if the condition is to be caught in time, since most cases are asymptomatic and hard to diagnose by other means.

13 Oct 2009

Gene sequencer donated for cardiovascular research

The Foundation has donated a latest-generation gene sequencer to the hospital's Cardiovascular Research Unit for use in its research project "Genetic testing in cardiovascular pathologies linked to sudden cardiac death among young athletes".

9 Oct 2009

Seizure News and Research

Latest Seizure News and Research

Compugen signs research and license agreement with a leading diagnostic company

EFOF's initative to raise epilepsy awareness

Cyberonics to develop medical devices with cutting edge technology for persons suffering from epilepsy

"Helmets for Hope" campaign launched to raise epilepsy disorder awareness

Therap Services to host its 4th annual National Provider Administrator conference in Fishkill

Genetic mutations cause for SIDS and SUDS

Protein crucial for insulin regulation may play a role in diabetes

Orexigen Therapeutics announces new data from COR-I, COR-II and COR-Diabetes trials for Contrave

TV program shares insights on epilepsy, diagnosis and treatment

EU policies threaten developing countries drug supplies, report says

Web site marketing fraudulent H1N1 flu supplements warned by the FDA and the FTC

Epilepsy Therapy Project unveils My Epilepsy Diary

FDA grants marketing approval for Elitek

Research study on epileptic seizures in individuals with alcohol withdrawal syndrome

Postive vote from FDA Advisory Committee for Fampridine-SR 10

Brain researcher finds how the epilepsy and pain drug works

National Vaccine Information Center to launch a research fundraising campaign

New neurosurgical procedure may prove helpful for patients with treatment-resistant depression

New study launched to detect DNA alterations linked to sudden cardiac death in sports

Gene sequencer donated for cardiovascular research

Everything you need to know about epilepsy eBook

Fluidics in Modern Healthcare & Medical Device Innovation

Scaling 3D biology: Automation, imaging, and the future of high-throughput research

How does norepinephrine influence anxiety-related behaviours?

Seizure News and Research

Latest Seizure News and Research

Everything you need to know about epilepsy eBook

Fluidics in Modern Healthcare & Medical Device Innovation

Scaling 3D biology: Automation, imaging, and the future of high-throughput research

How does norepinephrine influence anxiety-related behaviours?

Newsletters you may be interested in